• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童实体器官移植受者的巨细胞病毒感染:聚焦预防

Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.

作者信息

Tsai Karen C, Danziger-Isakov Lara A, Banach David B

机构信息

Yale School of Medicine, 800 Howard Avenue, New Haven, CT, USA.

Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 7017, Cincinnati, OH, USA.

出版信息

Curr Infect Dis Rep. 2016 Jan;18(2):5. doi: 10.1007/s11908-015-0511-8.

DOI:10.1007/s11908-015-0511-8
PMID:26743201
Abstract

Solid organ transplantation is a life-saving procedure that has changed the prognosis for infants and children with end-stage organ disease. Cytomegalovirus (CMV) is one of the most common infections that occur after organ transplantation in pediatric patients, yet the standard of care for CMV prevention remains unclear. We review the literature regarding CMV disease effects, risk factors, diagnostics, prevention strategies, and antiviral treatment in pediatric solid organ transplantation. This discussion focuses on the current prevention strategies: prophylaxis, preemptive, and hybrid therapy, as well as novel strategies that may help better prevent the CMV disease in the pediatric solid organ transplant population.

摘要

实体器官移植是一种挽救生命的手术,它改变了患有终末期器官疾病的婴幼儿和儿童的预后。巨细胞病毒(CMV)是儿科患者器官移植后最常见的感染之一,然而CMV预防的护理标准仍不明确。我们回顾了有关儿科实体器官移植中CMV疾病影响、危险因素、诊断、预防策略和抗病毒治疗的文献。本讨论聚焦于当前的预防策略:预防用药、抢先治疗和混合疗法,以及可能有助于更好地预防儿科实体器官移植人群中CMV疾病的新策略。

相似文献

1
Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.儿童实体器官移植受者的巨细胞病毒感染:聚焦预防
Curr Infect Dis Rep. 2016 Jan;18(2):5. doi: 10.1007/s11908-015-0511-8.
2
Prevention and treatment of cytomegalovirus infection in organ transplant recipients.器官移植受者巨细胞病毒感染的预防与治疗
Transpl Infect Dis. 1999 Sep;1(3):187-203. doi: 10.1034/j.1399-3062.1999.010307.x.
3
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.荟萃分析:巨细胞病毒预防实体器官移植受者器官疾病策略的疗效
Ann Intern Med. 2005 Dec 20;143(12):870-80. doi: 10.7326/0003-4819-143-12-200512200-00005.
4
A risk-stratified approach to cytomegalovirus prevention in pediatric solid organ transplant recipients.小儿实体器官移植受者巨细胞病毒预防的风险分层方法。
Pediatr Transplant. 2016 Nov;20(7):970-980. doi: 10.1111/petr.12786. Epub 2016 Aug 26.
5
Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.在抢先治疗期间巨细胞病毒感染风险较高的实体器官移植受者中的病毒载量、巨细胞病毒特异性T细胞免疫反应和巨细胞病毒疾病
Transpl Int. 2014 Oct;27(10):1060-8. doi: 10.1111/tri.12378. Epub 2014 Aug 20.
6
Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.针对巨细胞病毒血症的抢先治疗以预防实体器官移植受者的巨细胞病毒病
Transplantation. 2006 Jan 27;81(2):139-45. doi: 10.1097/01.tp.0000183970.71366.da.
7
A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients.小儿实体器官移植受者病毒性传染病管理的快速算法综述
Front Pediatr. 2023 Sep 4;11:1252495. doi: 10.3389/fped.2023.1252495. eCollection 2023.
8
Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients.实体器官和造血干细胞移植受者巨细胞病毒病的流行病学
Am J Health Syst Pharm. 2005 Apr 15;62(8 Suppl 1):S7-13. doi: 10.1093/ajhp/62.suppl_1.S7.
9
[Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].[实体器官移植后的巨细胞病毒感染、其危险因素、直接和间接影响以及预防策略]
Orv Hetil. 2008 Mar 23;149(12):551-8. doi: 10.1556/OH.2008.28324.
10
Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.儿科移植受者巨细胞病毒感染的当前预防和治疗管理策略。
Paediatr Drugs. 2002;4(5):279-90. doi: 10.2165/00128072-200204050-00001.

引用本文的文献

1
Multicenter Analysis of Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients.小儿实体器官移植受者中缬更昔洛韦预防的多中心分析
Open Forum Infect Dis. 2024 Jul 1;11(7):ofae353. doi: 10.1093/ofid/ofae353. eCollection 2024 Jul.
2
Healthcare disparity and its associations with cytomegalovirus disease in pediatric liver transplant recipients in South Africa.南非儿科肝移植受者的医疗保健差距及其与巨细胞病毒病的关系。
Transpl Infect Dis. 2022 Dec;24(6):e13917. doi: 10.1111/tid.13917. Epub 2022 Jul 29.
3
Impact of standardized protocols for cytomegalovirus disease prevention in pediatric solid organ transplant recipients.

本文引用的文献

1
Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir.儿童肾移植中的巨细胞病毒感染及(缬)更昔洛韦化学预防的影响
Transplantation. 2016 Apr;100(4):862-70. doi: 10.1097/TP.0000000000000888.
2
Assessment of Cytomegalovirus Hybrid Preventative Strategy in Pediatric Heart Transplant Patients.儿科心脏移植患者巨细胞病毒混合预防策略的评估
J Pediatric Infect Dis Soc. 2012 Dec;1(4):278-83. doi: 10.1093/jpids/pis056. Epub 2012 Jul 12.
3
Infections in Pediatric Solid Organ Transplant Recipients.
标准化方案对小儿实体器官移植受者巨细胞病毒病预防的影响。
Pediatr Transplant. 2019 Nov;23(7):e13568. doi: 10.1111/petr.13568. Epub 2019 Sep 13.
J Pediatric Infect Dis Soc. 2012 Jun;1(2):144-51. doi: 10.1093/jpids/pir001.
4
Cytomegalovirus infection in liver transplant recipients: updates on clinical management.肝移植受者的巨细胞病毒感染:临床管理的最新进展
World J Gastroenterol. 2014 Aug 21;20(31):10658-67. doi: 10.3748/wjg.v20.i31.10658.
5
Management of cytomegalovirus infection and disease in liver transplant recipients.肝移植受者巨细胞病毒感染及疾病的管理
World J Hepatol. 2014 Jun 27;6(6):370-83. doi: 10.4254/wjh.v6.i6.370.
6
Current prevention strategies against cytomegalovirus in the studies in pediatric liver transplantation (SPLIT) centers.小儿肝移植(SPLIT)中心研究中当前针对巨细胞病毒的预防策略。
Am J Transplant. 2014 Aug;14(8):1908-11. doi: 10.1111/ajt.12755. Epub 2014 Jun 5.
7
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.更昔洛韦预防造血细胞移植后巨细胞病毒感染。
N Engl J Med. 2014 May 8;370(19):1781-9. doi: 10.1056/NEJMoa1309533.
8
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.来氟米特预处理对肾移植受者巨细胞病毒感染的疗效:一项 2a 期研究结果。
Transpl Int. 2014 Jan;27(1):77-86. doi: 10.1111/tri.12225.
9
New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients.儿童实体器官移植受者中缬更昔洛韦给药的新算法
Pediatr Transplant. 2014 Feb;18(1):103-11. doi: 10.1111/petr.12179. Epub 2013 Oct 23.
10
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.CMX001 预防造血细胞移植中的巨细胞病毒病。
N Engl J Med. 2013 Sep 26;369(13):1227-36. doi: 10.1056/NEJMoa1303688.